サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1793774

再生療法の世界市場

Regenerative Therapies

出版日
ページ情報
英文 287 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.45円
再生療法の世界市場
出版日: 2025年08月19日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 287 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

再生療法の世界市場は2030年までに174億米ドルに達する

2024年に112億米ドルと推定される再生療法の世界市場は、2024年から2030年にかけてCAGR 7.7%で成長し、2030年には174億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである細胞療法は、CAGR9.2%を記録し、分析期間終了時には78億米ドルに達すると予測されます。幹細胞治療分野の成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は30億米ドルと推定、中国はCAGR12.3%で成長予測

米国の再生療法市場は、2024年に30億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに38億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.8％と7.5％と予測されています。欧州では、ドイツがCAGR 5.1%で成長すると予測されています。

世界の再生療法市場- 主要動向と促進要因のまとめ

なぜ再生療法が医療の未来を変えるのか？

再生療法は、病気や損傷を受けた細胞、組織、臓器を修復、置換、再生することを目的とした、先端医療における変革的なセグメントです。これらの治療法は、幹細胞、組織工学、遺伝子編集、生体工学的材料を活用し、身体の自然治癒プロセスを刺激します。従来の治療では、症状を抑えたり、病気の進行を止めたりすることが多かったが、再生療法では、生物学的機能を完全に回復させようとするものです。その応用範囲は、整形外科的損傷、心血管疾患、神経変性疾患、自己免疫疾患、さらには臓器再生にまで及ぶ。

幹細胞を用いた治療法、特に間葉系幹細胞（MSCs）は、特に軟骨再生、創傷治癒、虚血性疾患において最前線であり続けています。幹細胞は免疫調節作用を示し、複数の組織型に分化できるため、その有用性が高まっています。一方、人工多能性幹細胞（iPSC）は、免疫拒絶反応のリスクを低減した自家治療を推進しています。さらに、バイオスカフォールディングと3Dバイオプリンティングの進歩は、特に整形外科や再建医療において、構造的に実行可能な組織構築を可能にしています。これらの技術革新は、慢性疾患が細胞・分子レベルで対処されるようになるというパラダイム・シフトをもたらしつつあります。

新たな技術やプラットフォームは、臨床効果をどのように高めているのか？

この分野では、遺伝子編集細胞療法、既製の同種移植プラットフォーム、精密医療の統合によって急速な技術革新が進んでいます。CRISPR/Cas9や塩基編集技術は、有効性と耐久性を高めるために再生プロトコールに統合されつつあります。例えば、造血幹細胞の編集は、鎌状赤血球貧血やβサラセミアなどの血液疾患の潜在的治療法として浮上しています。さらに、エクソソームを含む細胞外小胞研究の進歩は、生細胞に関連するリスクを伴わずに再生可能性があるとして支持を集めています。

バイオマニュファクチャリングは、自動化、クローズドループシステム、一貫した製品品質のためのスケーラブルなプラットフォームによって進化しています。モジュール式クリーンルーム、ロボット式細胞培養システム、GMPに準拠した凍結保存技術により、コストが削減され、産業的なスケーラビリティが可能になりつつあります。AIと機械学習アルゴリズムは、患者固有のオミックスデータを分析し、再生治療への反応を予測し、臨床試験デザインを合理化するために導入されています。これらの技術は、特に多発性硬化症や1型糖尿病のような異質性の高い疾患において、新製品の市場投入までの時間を短縮し、治療精度を高めています。

市場需要を牽引している治療領域とデリバリーモデルは？

整形外科および筋骨格系への応用は、特に軟骨修復、腱再生、脊髄損傷において、現在の市場利用を支配しています。多血小板血漿（PRP）および幹細胞注射は、低侵襲であること、回復を促進するエビデンスがあることから、スポーツ医学および身体リハビリテーションにおいて広く使用されています。心血管系再生療法心不全や虚血肢の状態に対する心筋細胞置換や血管再生など、心血管系もまた勢いを増しています。神経疾患、特に脳卒中、パーキンソン病、ALSは、強力な研究パイプラインを持つ新興分野です。

医療提供モデルは、入院中の病院環境から、外来診療所、外来再生治療センター、専門的な整形生物学的診療所へと拡大しつつあります。このような分散化は、ポイントオブケア製造と小型化されたバイオプロセシングツールの進歩によって支えられています。同種細胞バンクは、より迅速な送達サイクルを可能にし、自家組織採取への依存を減らしています。コンパニオン診断、リアルタイムの画像診断、バイオマーカーによる投与戦略は、治療成績とモニタリングをさらに最適化しています。診断学、再生生体材料、デジタルヘルスツールの融合は、より全体的で適応性の高い送達エコシステムを可能にしています。

再生療法市場の成長を促進する要因は？

再生療法市場の成長は、アンメットクリニカルニーズ、人口動態の高齢化、支持的な規制の枠組み、官民からの投資の増加によってもたらされます。慢性疾患、加齢に伴う変性、外傷は、従来の治療法では十分に対処できないままであり、治療的または機能回復的な介入に対する根強い需要が生じています。北米、欧州、アジア太平洋の一部では人口の高齢化も進んでおり、変形性関節症、心血管疾患、神経変性における再生治療の必要性が高まっています。

米国FDAのRMAT（再生医療先進療法）指定や欧州のATMP（先進療法医薬品）規制パスウェイなどの政策的枠組みは、承認プロセスを迅速化し、イノベーションにインセンティブを与えています。さらに、何十億米ドルものベンチャー資金と官民パートナーシップが、臨床試験、研究インフラ、バイオ製造のスケールアップに拍車をかけています。NIH、CIRM（カリフォルニア再生医療研究所）、日本のAMEDのような機関が、世界の研究開発の機運を盛り上げています。有効性と価格に関する課題が解決される限り、再生療法は、ニッチなイノベーションから、負担の大きい治療領域全体の主流治療へと移行する態勢を整えています。

セグメント

治療タイプ（細胞治療、幹細胞治療、組織工学治療、遺伝子治療）、用途（創傷治療、筋骨格系、腫瘍学、歯科、デュシェンヌ型筋ジストロフィー、肝疾患、炎症性・自己免疫疾患、その他アプリケーション）

調査対象企業の例

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Biogen Inc.
  • Bristol Myers Squibb Company
  • Corestem, Inc.
  • Fate Therapeutics
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Integra LifeSciences Corporation
  • Medtronic plc
  • Merck KGaA
  • Mesoblast Ltd.
  • MiMedx Group, Inc.
  • Novartis AG
  • Organogenesis Holdings Inc.
  • Pfizer Inc.
  • Sarepta Therapeutics Inc.
  • Smith & Nephew plc
  • Takeda Pharmaceutical Company Limited
  • Vericel Corporation

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37887

Global Regenerative Therapies Market to Reach US$17.4 Billion by 2030

The global market for Regenerative Therapies estimated at US$11.2 Billion in the year 2024, is expected to reach US$17.4 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Cell Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the Stem Cell Therapy segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 12.3% CAGR

The Regenerative Therapies market in the U.S. is estimated at US$3.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 12.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Regenerative Therapies Market - Key Trends & Drivers Summarized

Why Are Regenerative Therapies Reshaping the Future of Medicine?

Regenerative therapies represent a transformative segment within advanced medicine, aiming to repair, replace, or regenerate diseased or damaged cells, tissues, or organs. These therapies leverage stem cells, tissue engineering, gene editing, and bioengineered materials to stimulate the body’s natural healing processes. Unlike conventional treatments that often manage symptoms or halt disease progression, regenerative therapies attempt to restore full biological function. Their applications extend across orthopedic injuries, cardiovascular diseases, neurodegenerative disorders, autoimmune diseases, and even organ regeneration.

Stem cell-based therapies, particularly mesenchymal stem cells (MSCs), remain at the forefront, especially in cartilage regeneration, wound healing, and ischemic diseases. They exhibit immunomodulatory effects and can differentiate into multiple tissue types, enhancing their utility. Meanwhile, induced pluripotent stem cells (iPSCs) are driving forward autologous treatments with reduced risk of immune rejection. Additionally, advancements in bio-scaffolding and 3D bioprinting are enabling structurally viable tissue constructs, especially in orthopedic and reconstructive medicine. These innovations are ushering in a paradigm shift where chronic ailments are increasingly addressed at a cellular and molecular level.

How Are Emerging Technologies and Platforms Enhancing Clinical Efficacy?

The field is undergoing rapid innovation through gene-edited cell therapies, off-the-shelf allogeneic platforms, and precision medicine integration. CRISPR/Cas9 and base editing technologies are being integrated into regenerative protocols to enhance efficacy and durability. For instance, editing hematopoietic stem cells is emerging as a potential cure for blood disorders like sickle cell anemia and beta-thalassemia. Furthermore, advancements in extracellular vesicle research, including exosomes, are gaining traction for their regenerative potential without the risks associated with live cells.

Biomanufacturing is evolving through automation, closed-loop systems, and scalable platforms for consistent product quality. Modular cleanrooms, robotic cell culture systems, and GMP-compliant cryopreservation techniques are reducing costs and enabling industrial scalability. AI and machine learning algorithms are being deployed to analyze patient-specific omics data, predict response to regenerative treatments, and streamline clinical trial design. These technologies are reducing time-to-market for new products and increasing therapeutic precision, particularly in diseases with high heterogeneity such as multiple sclerosis or Type 1 diabetes.

Which Therapeutic Areas and Delivery Models Are Driving Market Demand?

Orthopedic and musculoskeletal applications dominate current market usage, particularly in cartilage repair, tendon regeneration, and spinal cord injury. Platelet-rich plasma (PRP) and stem cell injections are widely used in sports medicine and physical rehabilitation due to their minimally invasive nature and evidence of enhanced recovery. Cardiovascular regenerative therapies are also gaining momentum, including myocardial cell replacement and vascular regeneration for heart failure and ischemic limb conditions. Neurological disorders-particularly stroke, Parkinson’s disease, and ALS-are emerging areas with a robust research pipeline.

Delivery models are expanding beyond inpatient hospital settings to include ambulatory clinics, outpatient regenerative therapy centers, and specialized orthobiologic practices. This decentralization is supported by advances in point-of-care manufacturing and miniaturized bioprocessing tools. Allogeneic cell banks are enabling faster delivery cycles and reduced dependency on autologous tissue harvesting. Companion diagnostics, real-time imaging, and biomarker-guided dosing strategies are further optimizing therapeutic outcomes and monitoring. The convergence of diagnostics, regenerative biomaterials, and digital health tools is enabling a more holistic and adaptive delivery ecosystem.

What Factors Are Driving the Growth of the Regenerative Therapies Market?

The growth in the regenerative therapies market is driven by unmet clinical needs, aging demographics, supportive regulatory frameworks, and increased investment from public and private sectors. Chronic diseases, age-related degeneration, and traumatic injuries remain inadequately addressed by conventional therapies, creating a persistent demand for curative or function-restoring interventions. Aging populations in North America, Europe, and parts of Asia-Pacific are also contributing to the need for regenerative solutions in osteoarthritis, cardiovascular disease, and neurodegeneration.

Policy frameworks such as the U.S. FDA’s RMAT (Regenerative Medicine Advanced Therapy) designation and Europe’s ATMP (Advanced Therapy Medicinal Products) regulatory pathway are expediting approval processes and incentivizing innovation. Additionally, billions of dollars in venture funding and public-private partnerships are fueling clinical trials, research infrastructure, and biomanufacturing scale-up. Institutions like the NIH, CIRM (California Institute for Regenerative Medicine), and Japan’s AMED are catalyzing global R&D momentum. As long as efficacy and affordability challenges are addressed, regenerative therapies are poised to move from niche innovation to mainstream treatment across high-burden therapeutic areas.

SCOPE OF STUDY:

The report analyzes the Regenerative Therapies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Therapy Type (Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy, Gene Therapy); Application (Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application, Duchenne Muscular Dystrophy Application, Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Biogen Inc.
  • Bristol Myers Squibb Company
  • Corestem, Inc.
  • Fate Therapeutics
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Integra LifeSciences Corporation
  • Medtronic plc
  • Merck KGaA
  • Mesoblast Ltd.
  • MiMedx Group, Inc.
  • Novartis AG
  • Organogenesis Holdings Inc.
  • Pfizer Inc.
  • Sarepta Therapeutics Inc.
  • Smith & Nephew plc
  • Takeda Pharmaceutical Company Limited
  • Vericel Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Regenerative Therapies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Breakthroughs in Stem Cell Research Propel Innovation in Regenerative Therapies
    • Advancements in 3D Bioprinting Technologies Expand Clinical Possibilities
    • Surge in Chronic Disease Prevalence Drives Adoption of Tissue Regeneration Solutions
    • Global Investments in Cell and Gene Therapy Manufacturing Facilities Accelerate Development
    • Rising Incidence of Degenerative Disorders Strengthens Market Opportunity
    • Patient-Centric Personalized Therapies Fuel Custom Regenerative Product Demand
    • Regulatory Pathway Clarity Across Major Markets Encourages Clinical Advancements
    • Cross-Industry Collaborations Propel Platform Technologies in Regenerative Medicine
    • Expansion of Clinical Trials for Musculoskeletal Disorders Spurs Therapy Validation
    • Government Funding for Translational Medicine Bolsters Therapy Commercialization
    • Emergence of Allogeneic Cell Platforms Reduces Production and Scalability Constraints
    • Integration of Artificial Intelligence Enhances Regenerative Drug Discovery Pipelines
    • Growing Demand for Anti-Aging Treatments Opens New Consumer-Facing Opportunities
    • Availability of Cryopreservation Infrastructure Enables Widespread Cell Banking
    • Academic and Industrial Partnerships Foster Advanced R&D Capabilities
    • Shift Toward Minimally Invasive Therapeutic Modalities Drives Delivery Innovation
    • Patient Awareness Campaigns Strengthen Demand for Regenerative Solutions
    • Increased Patent Activity Reflects Intensifying Innovation Race in Biologics
    • Expansion of Point-of-Care Manufacturing Models Optimizes Treatment Delivery
    • Ethical Acceptance and Regulatory Backing Improve Access in Emerging Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Regenerative Therapies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Regenerative Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Tissue engineering Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Tissue engineering Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Tissue engineering Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hepatological Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hepatological Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hepatological Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Inflammatory & Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Inflammatory & Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Inflammatory & Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Wound Care Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Wound Care Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Wound Care Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Musculoskeletal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Musculoskeletal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Musculoskeletal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Dental Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Dental Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Dental Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Duchenne Muscular Dystrophy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Duchenne Muscular Dystrophy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Duchenne Muscular Dystrophy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • CHINA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Regenerative Therapies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Regenerative Therapies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • INDIA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: India 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: India 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Regenerative Therapies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Regenerative Therapies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030

IV. COMPETITION